Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.68 |
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
| ▸ | GRB2 | P62993 | 1/20 | 0.53 |
| ▸ | ACACB | O00763 | 1/20 | 0.52 |
| ▸ | TPH1 | P17752 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | LCK | P06239 | 1/20 | 0.49 |
| ▸ | FYN | P06241 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2118353 | 1.00 | PTPN1 (0.68) | PTPN1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL1258519 | 1.00 | PTPN1 (0.68) | PTPN1SLC7A5PTGS1ALPIPKM | |
| Hydrochloric Acid SCHEMBL2309162 | 0.98 | PTPN1 (0.67) | PTPN1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL17658724 | 0.89 | PTPN1 (0.54) | PTPN1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL14945062 | 0.88 | PTPN1 (0.74) | PTPN1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL4946473 | 0.87 | PTPN1 (0.52) | PTPN1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL4946470 | 0.87 | PTPN1 (0.52) | PTPN1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL16080173 | 0.84 | ACACB (0.50) | PTPN1SLC7A5PTGS1ALPIPKM | |
| SCHEMBL2058886 | 0.84 | ACACB (0.53) | PTPN1ITGB3ITGA2BACACBPTGS2 | |
| SCHEMBL2311151 | 0.84 | ACACB (0.50) | PTPN1SLC7A5PTGS1ALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058841-A | Synthesis method of snake venom tetrapeptide | 上海鲲诺生物科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| EP-3650464-B1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | SHANGPHARMA INNOVATION INC (US) | 2025-11-05 | — | — | EP | disclosed |
| CN-120058841-A | Synthesis method of snake venom tetrapeptide | 上海鲲诺生物科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-20250171494-A1 | METHOD FOR SYNTHESIZING PEPTIDE CONTAINING N-SUBSTITUTED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-05-29 | — | — | US | disclosed |
| CN-119930814-A | D-peptide compounds directed against VEGF | 反射制药有限公司 | 2025-05-06 | — | — | CN | disclosed |
| EP-4545553-A2 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | ShangPharma Innovation Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-12281141-B2 | Method for synthesizing peptide containing N-substituted amino acid | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-04-22 | — | — | US | disclosed |
| EP-3647319-B1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER SHANGHAI CO LTD (CN) | 2025-04-09 | — | — | EP | disclosed |
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2024-10-29 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| EP-1487493-A2 | CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES | The Administrators of The Tulane Educational Fund (US) | 2004-12-22 | — | — | EP | disclosed |
| US-6723699-B1 | ADMINISTERING AS CHOLINERGIC AGENT TO TREAT NERVOUS SYSTEM DISORDERS | CEPHALON, INC. | 2004-04-20 | — | — | US | disclosed |
| US-6693076-B1 | ENHANCING SURVIVAL OF NEURONAL CELLS AT RISK OF DYING DUE TO INJURY OR EPILEPSY | CEPHALON, INC. | 2004-02-17 | — | — | US | disclosed |
| WO-2003074551-A2 | CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2003-09-12 | — | — | WO | disclosed |
| US-5580953-A | USEFUL IN THERAPY OF TYPE 2 DIABETES MELLITUS, IMPAIRED GLUCOSE TOLERANCE, OBESITY AND INSULIN RESISTANCE | AMYLIN PHARMACEUTICALS, INC. (US) | 1996-12-03 | — | — | US | disclosed |
| EP-0568687-A1 | NOVEL AMYLIN ANTAGONIST PEPTIDES AND USES THEREFOR | AMYLIN PHARMACEUTICALS, INC. (US) | 1993-11-10 | — | — | EP | disclosed |
| EP-0495963-A4 | IMPROVED HYPOGLYCEMICS | — | 1993-09-01 | — | — | EP | disclosed |
| WO-1993010147-A1 | NOVEL AMYLIN ANTAGONIST PEPTIDES AND USES THEREFOR | AMYLIN PHARMACEUTICALS, INC. (US) | 1993-05-27 | — | — | WO | disclosed |
| EP-0495963-A1 | IMPROVED HYPOGLYCEMICS | AMYLIN PHARMACEUTICALS, INC. (US) | 1992-07-29 | — | — | EP | disclosed |
| WO-1992003148-A1 | IMPROVED HYPOGLYCEMICS | AMYLIN CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | VIP, NGLY1, FURIN | PTPN1 765/4885SLC7A5 395/4885PTGS1 4110/4885 |
| US-20250171494-A1 | METHOD FOR SYNTHESIZING PEPTIDE CONTAINING N-SUBSTITUTED AMINO ACID | NPPA, VIP, DNPEP | PTPN1 4356/4885SLC7A5 61/4885PTGS1 3389/4885 |
| US-12281141-B2 | Method for synthesizing peptide containing N-substituted amino acid | NPPA, VIP, DNPEP | PTPN1 4356/4885SLC7A5 61/4885PTGS1 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.